Outcomes after heart transplantation in children under six years of age

Ari R Joffe1, Luis G Quiñonez, Charlene M T Robertson

  • 1Department of Pediatrics, School of Public Health, John Dossetor Health Ethics Center, University of Alberta, and Stollery Children's Hospital, Edmonton, Alberta, Canada. ari.joffe@albertahealthservices.ca

Insights

Pediatric heart transplant recipients often experience developmental delays, especially those with congenital heart disease (CHD). Early intervention and close follow-up are crucial for improving outcomes in these young survivors.

Area of Science:

  • Pediatric Cardiology
  • Developmental Pediatrics
  • Transplant Medicine

Background:

  • Improved survival rates post-pediatric heart transplant necessitate focus on developmental outcomes.
  • Assessing neurodevelopmental trajectories in young heart transplant recipients is critical.

Purpose of the Study:

  • To determine survival, morbidity, and developmental outcomes in children under six undergoing heart transplant.
  • To identify predictors of neurodevelopmental outcomes in this cohort.

Main Methods:

  • Inception cohort study of 33 children under six undergoing heart transplant (1999-2006).
  • Collected pretransplant, transplant, and posttransplant data.
  • Used univariate and multiple regression analyses for neurodevelopmental outcomes at least 12 months posttransplant.

Main Results:

  • 12% mortality; survivors frequently exhibited low weight (28%) and height (31%).
  • High rates of language (41%), motor (52%), mental (34%), and adaptive (48%) delays observed.
  • Congenital heart disease (CHD) was significantly associated with death-disability-mental delay (OR 7.94, p=0.011) and mental/language delay.

Conclusions:

  • Adverse neurodevelopmental outcomes are common in pediatric heart transplant survivors, particularly those with CHD.
  • Pre- and post-transplant counseling and early intervention are essential for high-risk children.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.